NEWS

2025313

Other Heartseed has started CEO column, "TOP MESSAGE", on Investor Relation section of its website.

202523

PR Heartseed Announces Enrollment Completion in Phase 1/2 Clinical Trial using HS-001, an Investigational Stem Cell-Derived Therapy for Advanced Heart Failure

20241223

Congress CEO Keiichi Fukuda will present at the 9th Annual Symposium of the Center of Definitive and Curative Medicine at Stanford.

2024122

Congress Takehiko Kaneko, CMO of Heartseed, to Speak at the Global CVCT Forum

20241114

Media CEO Keiichi Fukuda Interviewed by BiotechTV

2024115

Seminar The speech given by CEO Keiichi Fukuda at the Nikkei Forum "Investing in Japanese Regenerative Medicine", held on September 17, 2024, has been posted on the NIKKEI ASIA website.

20241021

Congress Heartseed COO Kikuo Yasui is Speaking at the "2nd Cell & Gene Tech Investment Forum" in South Korea on October 25.

2024108

Media Heartseed was featured on CNN's "Tomorrow Transformed".

2024101

PR Notice Concerning Positive Recommendation from Safety Monitoring Committee for Continuing High-dose Arm in HS-001 Clinical Trial (LAPiS Study)

2024916

Seminar Heartseed CMO Takehiko Kaneko is Speaking at the "Global Innovations in Healthcare" Webinar

1 2 3 4 5 6 7 8